• Fri, November 11, 2022
Serge Belanger Maintained (TRVI) at Strong Buy with Decreased Target to $8 on, Nov 11th, 2022
Serge Belanger of Needham, Maintained "Trevi Therapeutics, Inc." (TRVI) at Strong Buy with Decreased Target from $10 to $8 on, Nov 11th, 2022.
Serge, nor any peers, have made any analyst calls on TRVI in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
